Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study
- PMID: 31673597
- PMCID: PMC6816447
- DOI: 10.1016/j.dadm.2019.08.004
Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study
Abstract
Introduction: We aimed to examine the contribution of subjective cognitive decline (SCD) to reduce the number of β-amyloid (Aβ) positron emission tomography scans required for recruiting Aβ+ clinically normal individuals in clinical trials.
Methods: Three independent cohorts (890 clinically normal: 72 yrs ± 6.7; Female: 43.4%; SCD+: 24%; apolipoprotein E [APOE] ε4+: 28.5%; Aβ+: 32%) were used. SCD was dichotomized from one question. Using logistic regression, we classified Aβ+ using the SCD dichotomy, APOEε4, sex, and age.
Results: SCD increased odds of Aβ+ by 1.58 relative to non-SCD. Female APOEε4 carriers with SCD exhibited higher odds of Aβ+ (OR = 3.34), whereas male carriers with SCD showed a weaker, opposing effect (OR = 0.37). SCD endorsement reduces the number of Aβ positron emission tomography scans to recruit Aβ+ individuals by 13% and by 9% if APOEε4 status is known.
Conclusion: SCD helps to classify those with high Aβ, even beyond the substantial effect of APOE genotype. Collecting SCD is a feasible method for targeting recruitment for those likely on the AD trajectory.
Keywords: APOEε4; Alzheimer's disease; Amyloid; Subjective cognitive decline.
© 2019 The Authors.
Figures
References
-
- Rowe C.C., Ellis K., Rimajova M., Bourgeat P., Pike K.E., Jones G. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging. 2010;31:1275–1283. - PubMed
Grants and funding
- K24 AG035007/AG/NIA NIH HHS/United States
- R01 AG037497/AG/NIA NIH HHS/United States
- S10 RR021110/RR/NCRR NIH HHS/United States
- R01 AG027435/AG/NIA NIH HHS/United States
- K23 EB019023/EB/NIBIB NIH HHS/United States
- R21 AG038994/AG/NIA NIH HHS/United States
- P50 AG005134/AG/NIA NIH HHS/United States
- K99 AG061238/AG/NIA NIH HHS/United States
- K23 AG049087/AG/NIA NIH HHS/United States
- R01 AG034556/AG/NIA NIH HHS/United States
- R01 EB014894/EB/NIBIB NIH HHS/United States
- R01 AG026484/AG/NIA NIH HHS/United States
- U01 AG032438/AG/NIA NIH HHS/United States
- P30 AG062421/AG/NIA NIH HHS/United States
- P01 AG036694/AG/NIA NIH HHS/United States
- U01 AG024904/AG/NIA NIH HHS/United States
- U19 AG010483/AG/NIA NIH HHS/United States
- K01 AG051718/AG/NIA NIH HHS/United States
- S10 RR023043/RR/NCRR NIH HHS/United States
- P41 EB015896/EB/NIBIB NIH HHS/United States
- S10 RR023401/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous